- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 211/76 - Oxygen atoms attached in position 2 or 6
Patent holdings for IPC class C07D 211/76
Total number of patents in this class: 270
10-year publication summary
|
24
|
25
|
15
|
21
|
21
|
21
|
17
|
15
|
18
|
10
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Amgen Inc. | 4420 |
23 |
| California Institute of Technology | 4035 |
8 |
| Bristol-myers Squibb Company | 4721 |
7 |
| Codexis, Inc. | 816 |
7 |
| The Scripps Research Institute | 1342 |
7 |
| Arvinas Operations, Inc. | 261 |
7 |
| Takeda Pharmaceutical Company Limited | 2717 |
6 |
| InterMune, Inc. | 48 |
5 |
| Daikin Industries, Ltd. | 10456 |
4 |
| Institut Univ. de Ciencia i Tecnologia, S.A. | 22 |
4 |
| Queen's University at Kingston | 540 |
4 |
| Tetraphase Pharmaceuticals, Inc. | 52 |
4 |
| BASF SE | 21294 |
3 |
| Pfizer Inc. | 3386 |
3 |
| Merck Patent GmbH | 5727 |
3 |
| Abbott Laboratories | 2259 |
3 |
| Cedars-Sinai Medical Center | 1195 |
3 |
| ChemoCentryx, Inc. | 367 |
3 |
| Cocrystal Pharma, Inc. | 44 |
3 |
| Dart NeuroScience, LLC | 50 |
3 |
| Other owners | 160 |